In addition, a synergistic antitumor effect was achieved when combining the IL‐1β and PD‐1 blockade in the LLC tumor‐bearing mouse model (Figure S13A–C), and anti‐IL‐1β antibodies also reversed the suppressive TIME of LLC tumors (Figure S13D–I). The gene discussed is IL1B; the disease is neoplasm.